Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs Fifth Third Bancorp Common Stock (FITB) Price & Performance

Ginkgo Bioworks Holdings IncTrade
Fifth Third Bancorp Common StockTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs Fifth Third Bancorp Common Stock — how do they compare? Ginkgo Bioworks Holdings Inc trades at $12.95 (market cap $763.64M), while Fifth Third Bancorp Common Stock trades at $50.53 (market cap $45.98B). The key difference: Fifth Third Bancorp Common Stock is far larger — about 60.2× Ginkgo Bioworks Holdings Inc's market cap, and Fifth Third Bancorp Common Stock pays a 3.31% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Fifth Third Bancorp Common Stock for 1 Days on average.

DNAFITB
Market Cap
$763.64M$45.98B
Volume
3,204,17710,522,320
Sector
HealthFinancials
52-Week High
$15.83$59.37
52-Week Low
$5.48$40.36
Typical Hold Time
7 Days1 Days
Enterprise Value
$865.59M$63.85B
Dividend Yield
—3.31%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $13.04, up 13.69% in the last session, with a bullish technical signal from moving averages. The company maintains strong gross margins at 68.04% but faces significant losses with a -219.6% net income margin. Recent developments include a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnerships expanding genetic testing distribution.

While technical momentum appears positive, fundamental challenges persist with substantial cash burn and declining revenue projections. Analyst sentiment is divided equally between buy, hold, and sell ratings. Investment opportunity lies in the company's strategic partnerships and government contracts, balanced against ongoing profitability concerns and competitive pressures in biotech.

Fifth Third Bancorp Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DNA
47% Buy53% Sell
Avg holding period · 7 Days
FITB

No sentiment data available yet.

Top news

Latest headlines on both assets

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →

About Fifth Third Bancorp Common Stock

Fifth Third Bancorp provides retail and commercial banking, lending, payments, and wealth management services in the United States.

Read more on FITB →